US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Johnson & Johnson

154.58

-0.3500-0.23%

Post-market: 153.90-0.6801-0.44%19:57 EDT

Volume:8.64M

Turnover:1.33B

Market Cap:371.93B

PE:17.20

High:154.90

Open:154.32

Low:152.45

Close:154.93

Loading ...

Overview Company News Filings

Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded

BUZZ-Genmab falls after J&J Hexabody opt-out

Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)

Are High-Yield Dividend Stocks Best for Income-Focused Investors?

How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket

Johnson & Johnson's Ulcerative Colitis Drug Hits Key Trial Goals, Stock Rises

Top Midday Gainers

MT Newswires Live

Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024

BRIEF-Genmab Says Johnson & Johnson Will Not Exercise Option For Hexabody-Cd38 License

Expectations for J&J Genmab opt-in lowered ahead of news, says Morgan Stanley

Genmab’s HexaBody-CD38 Development Halted After J&J Decision

BRIEF-J&J's oral drug to treat inflammation-causing condition in colon meets main goal in mid-stage study

Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson

Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson

Genmab Says Johnson & Johnson Declines Global License Option for HexaBody-CD38; Shares Fall

MT Newswires Live

Genmab Stops Blood Cancer Treatment Development After J&J Won't License It

Genmab says J&J not exercising option on HexaBody-CD38

Genmab a/S - News Does Not Impact Genmab's 2025 Financial Guidance

THOMSON REUTERS

Genmab a/S - Johnson & Johnson Will Not Exercise Option for Hexabody-Cd38 License

THOMSON REUTERS

Genmab a/S - Will Not Pursue Further Clinical Development of Hexabody-Cd38

THOMSON REUTERS

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/JNJ/news?page=20"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"JNJ","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","market":"US","secType":"STK","nameCN":"Johnson & Johnson","latestPrice":154.58,"timestamp":1745611200000,"preClose":154.93,"halted":0,"volume":8643927,"hourTrading":{"tag":"盘后","latestPrice":153.8999,"preClose":154.58,"latestTime":"19:57 EDT","volume":241532,"amount":37335647.5779,"timestamp":1745625466923},"delay":0,"floatShares":2402378994,"shares":2406073279,"eps":8.984973,"marketStatus":"Market Closed","change":-0.35,"latestTime":"04-25 16:00:00 EDT","open":154.32,"high":154.9,"low":152.45,"amount":1330911231.6210902,"amplitude":0.015814,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":8.984973,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1745827200000},"marketStatusCode":7,"adr":0,"adrRate":0,"listingDate":-797371200000,"exchange":"NYSE","adjPreClose":154.93,"dividendRate":0.032087,"preHourTrading":{"tag":"盘前","latestPrice":154.26,"preClose":154.93,"latestTime":"09:29 EDT","volume":3621,"amount":560780.2869,"timestamp":1745587772890},"postHourTrading":{"tag":"盘后","latestPrice":153.8999,"preClose":154.58,"latestTime":"19:57 EDT","volume":241532,"amount":37335647.5779,"timestamp":1745625466923},"volumeRatio":1.033507316421939,"optionData":{"bulkOrders":[{"symbol":"JNJ","call":true,"expireDate":1745553600000,"strike":"155.0","timestamp":1745588586409,"price":0.2,"volume":1994,"amount":39880,"type":"+"}]},"impliedVol":0.2478,"impliedVolPercentile":0.936},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"JNJ\",,,,,undefined,":{"symbol":"JNJ","floatShares":2402378994,"roa":"7.74%","roe":"29.45%","lyrEps":5.84306,"volumeRatio":1.033507316421939,"shares":2406073279,"dividePrice":4.96,"high":154.9,"amplitude":0.015814,"preClose":154.93,"low":152.45,"week52Low":140.68,"pbRate":"4.76","psRate":"4.16","week52High":169.99,"institutionHeld":0.6213,"latestPrice":154.58,"eps":8.984973,"divideRate":0.032087,"volume":8643927,"delay":0,"ttmEps":8.984973,"open":154.32,"prevYearClose":144.62,"prevWeekClose":157.47,"prevMonthClose":165.84,"prevQuarterClose":165.84,"fiveDayClose":157.47,"twentyDayClose":163.13,"sixtyDayClose":151.15},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"JNJ\",pageSize:20,pageCount:20,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2518748469","title":"Genmab sinks as J&J opts not to develop Darzalex successor; stock upgraded","url":"https://stock-news.laohu8.com/highlight/detail?id=2518748469","media":"Investing.com","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518748469?lang=en_us&edition=fundamental","pubTime":"2025-03-11 19:06","pubTimestamp":1741691214,"startTime":"0","endTime":"0","summary":"Investing.com -- Genmab   announced on Monday, March 10, that Johnson&Johnson  has chosen not to proceed with the development of GEN3014 , a next-gen version of their megablockbuster cancer drug, Darzalex.Genmab’s U.S.-listed shares closed 9% lower Monday and fell by an additional 3.6% in Tuesday’s premarket trade.GEN3014, also known as HexaBody-CD38, is an investigational monoclonal antibody developed by Genmab that targets the CD38 protein on multiple myeloma cells, enhancing immune-mediated tumor cell destruction.The company held an investor call to discuss the decision, during which it shared initial data from a head-to-head study comparing GEN3014 to Darzalex.While the results suggested potentially deeper responses, they were not compelling enough for J&J or Genmab to pursue further development of GEN3014 for other indications.Following the post-announcement stock pullback, analysts at William Blair upgraded Genmab stock to an Outperform rating.“With a steady cadence of Phase III ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/genmab-sinks-j-j-opts-110654356.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["JNJ","GMAB"],"gpt_icon":0},{"id":"2518953787","title":"BUZZ-Genmab falls after J&J Hexabody opt-out","url":"https://stock-news.laohu8.com/highlight/detail?id=2518953787","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518953787?lang=en_us&edition=fundamental","pubTime":"2025-03-11 16:20","pubTimestamp":1741681247,"startTime":"0","endTime":"0","summary":"BUZZ-Genmab falls after J&J Hexabody opt-out** Shares in Genmab GMAB.CO fall 5.4% after Johnson & Johnson JNJ.N opted out of further clinical development of the Hexabody-CD38 cancer drug on Monday** Van Lanschot Kempen says that Hexabody did not differentiate enough from Darzalex, the company's flagship drug, and neither Genmab nor J&J will take the project forward** While Kempen says \"the shares are now free to perform\" without this overhang, Jyske Bank does not expect a quick rebound but rather a slow regain of market confidence** Kempen expects continued earnings momentum and growing appreciation for another cancer drug Epkinly as a major growth driver** Genmab says J&J opt-out does not impact its 2025 guidance  ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250311:nL8N3PU0BD:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0889566641.SGD","IE000M9KFDE8.USD","IE00B19Z3B42.SGD","IE00BVYPNV92.GBP","LU1023059063.AUD","LU1261432733.SGD","LU0466842654.USD","JNJ","LU2430703095.HKD","IE00B7SZLL34.SGD","LU1267930813.SGD","LU2505996681.GBP","LU0058720904.USD","LU0882574055.USD","BK4007","LU2133065610.SGD","LU1074936037.SGD","BK4559","SG9999002232.USD","IE00BJJMRZ35.SGD","LU1718418525.SGD","LU2129689605.HKD","IE00BGHQF631.EUR","IE0002141913.USD","LU0234570918.USD","LU1280957306.USD","LU1221951129.SGD","LU0792757196.USD","LU1244550494.USD","BK4534","BK4592","LU1244550221.USD","LU0122379950.USD","IE00BDGV0183.EUR","LU0640476718.USD","LU2505996509.AUD","BK4585","LU0203345920.USD","SG9999001440.SGD","LU0234572021.USD","LU1066051498.USD","LU2430703251.USD","IE0009355771.USD","IE00B3PB1722.GBP","LU0289739699.SGD","LU2129689514.USD","LU1059921491.USD","LU2592432038.USD","LU1935042991.SGD","BK4532"],"gpt_icon":0},{"id":"2518762071","title":"Analysts’ Opinions Are Mixed on These Healthcare Stocks: BridgeBio Pharma (BBIO), Johnson & Johnson (JNJ) and Lexicon Pharmaceuticals (LXRX)","url":"https://stock-news.laohu8.com/highlight/detail?id=2518762071","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518762071?lang=en_us&edition=fundamental","pubTime":"2025-03-11 15:31","pubTimestamp":1741678265,"startTime":"0","endTime":"0","summary":"Companies in the Healthcare sector have received a lot of coverage today as analysts weigh in on BridgeBio Pharma (BBIO – Research Report), Johnson...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-bridgebio-pharma-bbio-johnson-johnson-jnj-and-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/analysts-opinions-are-mixed-on-these-healthcare-stocks-bridgebio-pharma-bbio-johnson-johnson-jnj-and-lexicon-pharmaceuticals-lxrx?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["LU1778281490.HKD","IE00B3PB1722.GBP","LU1244550577.SGD","LU1935042991.SGD","LU1718418525.SGD","LU1732800096.USD","LU1674673691.USD","LU1162221912.USD","IE00B4R5TH58.HKD","LU0234572021.USD","BK4139","IE0034235303.USD","LU0098860793.USD","LU1914381329.SGD","BK4581","LXRX","BBIO","LU0234570918.USD","IE00BVYPNV92.GBP","LU0795875086.SGD","LU1280957306.USD","LU1894683348.USD","BK4550","JNJ","LU2430703251.USD","IE0002141913.USD","IE00BDGV0183.EUR","LU1023059063.AUD","BK4585","LU0345770308.USD","LU0889566641.SGD","LU0882574055.USD","LU1059921491.USD","LU1066053197.SGD","LU0792757196.USD","LU1261432733.SGD","LU2129689514.USD","LU2430703095.HKD","IE00BJT1NW94.SGD","BK4504","BK4559","BK4007","HCSG","BK4534","SG9999002232.USD","LU0345769631.USD","BK4533","LU0114720955.EUR","LU1267930813.SGD","IE00B19Z3B42.SGD"],"gpt_icon":0},{"id":"2518733224","title":"Are High-Yield Dividend Stocks Best for Income-Focused Investors?","url":"https://stock-news.laohu8.com/highlight/detail?id=2518733224","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518733224?lang=en_us&edition=fundamental","pubTime":"2025-03-11 07:04","pubTimestamp":1741647840,"startTime":"0","endTime":"0","summary":"When selecting dividend-paying stocks, one of the first things that investors look at is, of course, the annual yield.But are high-yield stocks always the best route for income-focused investors?At a quick glance, a dividend-paying stock with a steep annual yield indeed seems like a solid investment from an income-focused standpoint. This is particularly true from a shorter-term perspective, but it’s not always that simple and clear-cut.The risk to the initial investment is often greater in these situations, given the already negative sentiment causing poor price action. Remember, stocks can always go lower than previously thought, and you don’t want to get trapped in bearish price action.But for those who seek reliability, targeting companies that have a rich history of increasing payouts are prime considerations. Dividend Aristocrats reflect these companies, as companies in the club have upped their dividend payouts for a minimum of 25 consecutive years and are included in the S&P 50","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/high-yield-dividend-stocks-best-230400738.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B3PB1722.GBP","LU2129689514.USD","LU0061475181.USD","LU1066051811.HKD","LU1670710661.SGD","LU1868836757.USD","BK4568","LU2112291526.USD","US12M.BOND","LU1670711040.USD","LU1023059063.AUD","LU0792757196.USD","JNJ","LU2360032135.SGD","US10Y.BOND","LU1162221912.USD","LU0203347892.USD","LU1732799900.SGD","IE0002141913.USD","US3Y.BOND","IE00B19Z3B42.SGD","LU2592432038.USD","US30Y.BOND","LU0289739699.SGD","IE00BVYPNV92.GBP","IE00B19Z3581.USD","US5Y.BOND","LU0689626769.HKD","LU2347655156.SGD","PG","LU0640476718.USD","LU0124676726.USD","BK4588","LU1074936037.SGD","LU2129689605.HKD","LU2237443549.SGD","US6M.BOND","US7Y.BOND","LU0094547139.USD","IE00BJJMRZ35.SGD","LU1066051498.USD","ISBC","LU0345770993.USD","LU2552382058.USD","KO","LU1057294990.SGD","US2Y.BOND","LU0795875169.SGD","LU1585245621.USD","LU0234570918.USD"],"gpt_icon":1},{"id":"2518202403","title":"How Exxon Mobil, Johnson & Johnson, And Cogent Communications Can Put Cash In Your Pocket","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202403","media":"Benzinga","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518202403?lang=en_us&edition=fundamental","pubTime":"2025-03-11 03:30","pubTimestamp":1741635018,"startTime":"0","endTime":"0","summary":"Exxon Mobil Corporation  engages in the exploration and production of crude oil and natural gas in the U.S. and internationally.Exxon Mobil has raised its dividends every year for the last 42 years. According to its most recent dividend hike announcement on Nov. 1, the company increased the quarterly payout by 4% to $0.99 per share, which is equal to an annual figure of $3.96 per share. The current dividend yield is 3.76%.Exxon Mobil’s annual revenue as of Dec. 31 stood at $339.25 billion. In its Q4 2024 earnings release on Jan. 31, the company posted quarterly revenues of $83.43 billion, missing the consensus estimate of $87.20 billion, while EPS of $1.67 came in above the consensus of $1.55.If you invested $10,000 in Exxon Mobil stock 10 years ago, how much would you have now?Cogent Communications has increased its dividend consecutively for the last 13 years. As per the company's most recent dividend announcement on Feb. 27, its board of directors raised the quarterly payout by $0.0","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/exxon-mobil-johnson-johnson-cogent-193018690.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["SG9999001440.SGD","BK4585","LU0456855351.SGD","LU2125154935.USD","LU1934455194.USD","LU0096364046.USD","BK4581","TSYW.SI","LU1894683348.USD","LU1839511570.USD","LU2756315664.SGD","IE00BBT3K403.USD","LU2290526834.HKD","BK4534","IE00B3CCJ963.GBP","BK4570","LU2456880835.USD","IE00B19Z3581.USD","LU0198837287.USD","LU1066051811.HKD","LU0109392836.USD","LU1242518857.USD","LU1032466523.USD","LU1868837300.USD","LU2247934214.USD","CCOI","IE00BWXC8680.SGD","LU0672654240.SGD","LU0654597011.USD","IE00B1BXHZ80.USD","IE00B7SZLL34.SGD","LU1037948541.HKD","LU2077746001.SGD","LU1732799900.SGD","MACW.SI","BK4588","LU0345768740.USD","LU2083900584.USD","JNJ","IE000M9KFDE8.USD","LU0354030511.USD","XOM","IE00BJTD4V19.USD","LU1066053197.SGD","IE0003U64NQ7.SGD","LU1670627923.USD","BK4507","LU1629891620.HKD"],"gpt_icon":1},{"id":"2518202266","title":"Johnson & Johnson's Ulcerative Colitis Drug Hits Key Trial Goals, Stock Rises","url":"https://stock-news.laohu8.com/highlight/detail?id=2518202266","media":"GuruFocus.com","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518202266?lang=en_us&edition=fundamental","pubTime":"2025-03-11 03:14","pubTimestamp":1741634094,"startTime":"0","endTime":"0","summary":"Johnson & Johnson  announced Monday that its oral treatment, icotrokinra, met the main goal in a mid-stage trial for ulcerative colitis, boosting JNJ stock by 1% in early trading.The study evaluated icotrokinra, a targeted oral peptide that blocks the IL-23 receptor, in adults with moderate to severe ulcerative colitis. Results showed positive responses across all tested doses, with the drug also meeting secondary goals, including clinical remission, symptom reduction, and endoscopic improvement.At Week 12, 63.5% of patients on the highest dose showed improvement, compared to 27% in the placebo group. Additionally, 30.2% of patients on the highest dose achieved clinical remission, versus 11.1% on placebo, according to JNJ.The company also noted that icotrokinra was well tolerated, with similar side effect rates between the treatment and placebo groups. These results position JNJ's investigational drug as a potential new option for ulcerative colitis patients seeking effective oral trea","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/johnson-johnsons-ulcerative-colitis-drug-191454869.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["IE00B1BXHZ80.USD","LU1032955483.USD","LU1280957306.USD","JNJ","LU2430703095.HKD","IE00B4R5TH58.HKD","IE0002270589.USD","LU1066051225.USD","LU1261432733.SGD","BK4581","LU1059921491.USD","LU1732799900.SGD","IE000M9KFDE8.USD","LU2468319806.SGD","LU1023059063.AUD","LU1032466523.USD","LU1244550494.USD","LU0345770993.USD","IE0002141913.USD","LU1162221912.USD","LU0098860793.USD","LU2430703178.SGD","LU1066051811.HKD","IE0034235303.USD","LU1674673428.USD","BK4550","BK4559","LU2430703251.USD","LU1718418525.SGD","LU0882574055.USD","BK4534","LU2112291526.USD","IE00B19Z3581.USD","LU1894683348.USD","IE00B7SZLL34.SGD","IE00B19Z3B42.SGD","BK4585","IE00BGHQF631.EUR","IE0009355771.USD","LU0345769631.USD","LU2133065610.SGD","BK4504","IE00B3PB1722.GBP","LU0203345920.USD","LU0466842654.USD","BK4588","LU1066053197.SGD","LU0203347892.USD","SG9999001440.SGD","IE00BFTCPJ56.SGD"],"gpt_icon":1},{"id":"2518520936","title":"Top Midday Gainers","url":"https://stock-news.laohu8.com/highlight/detail?id=2518520936","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518520936?lang=en_us&edition=fundamental","pubTime":"2025-03-11 02:28","pubTimestamp":1741631308,"startTime":"0","endTime":"0","summary":"Mineralys Therapeutics (MLYS) said Monday that lorundrostat met primary endpoints in phase 3 Launch-HTN and phase 2 Advance-HTN trials in patients with uncontrolled hypertension or resistant hypertens","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1674673428.USD","BK4592","LU0345770308.USD","LU1732799900.SGD","LU2430703251.USD","RKT.AU","LU0203347892.USD","BK4079","LU1023059063.AUD","IE00B3PB1722.GBP","SG9999001440.SGD","LU1059921491.USD","BK4504","LU1074936037.SGD","RKT","BK4559","LU1244550494.USD","BK4532","IE00B2B36J28.USD","LU0795875086.SGD","BK4139","LU0345769128.USD","BK4568","BK4581","LU1057294990.SGD","LU0640476718.USD","BK4585","LU1674673691.USD","LU1061106388.HKD","LU1778281490.HKD","BK7084","BK4007","IE00B19Z3581.USD","LU0289739699.SGD","BK4588","LU1196500208.SGD","RDFN","IE00BJJMRZ35.SGD","LU2347655156.SGD","MLYS","LU2592432038.USD","LU2129689431.USD","IE00B4R5TH58.HKD","BK4533","LU1894683264.USD","IE000M9KFDE8.USD","JNJ","PTGX","LU1267930813.SGD","IE00BGHQF631.EUR"],"gpt_icon":1},{"id":"2518062192","title":"Eli Lilly CEO David Ricks' pay rose to almost $30 million in 2024","url":"https://stock-news.laohu8.com/highlight/detail?id=2518062192","media":"Quartz","labels":["executive"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518062192?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:16","pubTimestamp":1741626983,"startTime":"0","endTime":"0","summary":"David Ricks, Chair and C.E.O. of Eli Lilly and Company, speaks during the New York Times annual DealBook summit at Jazz at Lincoln Center on December 04, 2024 in New York City. - Image: Michael M. Santiago / Staff . Eli Lilly  CEO David Ricks got a 10% raise in 2024, as a surge in demand for weigh-loss drugs has propelled the pharma giant into the most valuable pharmaceutical company in the world.Ricks’ total compensation for 2024 reached $29.2 million, according to the company’s latest proxy statement, up from $26.6 million in 2023. When he became CEO in 2017, Ricks’ annual compensation started at $15.8 million.In that time, Eli Lilly has seen explosive growth, largely due to its blockbuster diabetes and weight-loss drugs, Mounjaro and Zepbound.Mounjaro brought in $11.5 billion in sales in 2024, while Zepbound generated $4.9 billion in annual revenue.The company’s strong performance has also boosted its stock price. Eli Lilly’s stock has climbed 10% over the past 12 months to about $8","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/eli-lilly-ceo-david-ricks-171623903.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"executive","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2063271972.USD","LU0096364046.USD","LU1548497426.USD","LU0820562030.AUD","LU1267930227.SGD","LU1989772923.USD","LU0820561818.USD","LU2237443465.HKD","LU0109391861.USD","IE00B19Z8X17.USD","LU1037948541.HKD","SG9999002232.USD","LU1674673691.USD","LU0310799852.SGD","LU2491050071.SGD","LU1551013425.SGD","LU0528227936.USD","LLY","BK4568","LU1093756168.USD","LU1732800096.USD","SG9999001176.USD","SG9999018865.SGD","LU2237443895.HKD","LU2362541273.HKD","LU0006306889.USD","LU0820561909.HKD","LU1003077747.HKD","LU2106854487.HKD","LU2125154778.USD","IE00B19Z9505.USD","BK4007","LU0965509010.AUD","LU2362541513.USD","IE00BFSS7M15.SGD","JNJ","LU1069344957.HKD","LU0965509283.SGD","IE00BJJMRY28.SGD","LU0456855351.SGD","LU0976567544.SGD","LU1989772840.SGD","IE00B19Z9P08.USD","SGXZ31699556.SGD","LU0861579265.USD","LU2244417387.USD","LU0787776722.HKD","SG9999014898.SGD"],"gpt_icon":1},{"id":"2518620815","title":"BRIEF-Genmab Says Johnson & Johnson Will Not Exercise Option For Hexabody-Cd38 License","url":"https://stock-news.laohu8.com/highlight/detail?id=2518620815","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518620815?lang=en_us&edition=fundamental","pubTime":"2025-03-11 01:08","pubTimestamp":1741626499,"startTime":"0","endTime":"0","summary":"BRIEF-Genmab Says Johnson & Johnson Will Not Exercise Option For Hexabody-Cd38 LicenseMarch 10 (Reuters) - Genmab A/S GMAB.CO:GENMAB ANNOUNCES JOHNSON & JOHNSON DECISION REGARDING HEXABODY-CD38GENMAB ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA8D268K:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1074936037.SGD","LU0466842654.USD","IE00BGHQF631.EUR","LU1261432733.SGD","IE00BVYPNW00.USD","LU2505996681.GBP","IE00BJJMRZ35.SGD","LU1023059063.AUD","BK4585","LU1057294990.SGD","LU2347655156.SGD","SG9999002224.SGD","IE0002141913.USD","BK4007","LU2430703178.SGD","LU1059921491.USD","LU0795875169.SGD","LU2112291526.USD","LU1732800096.USD","LU0882574055.USD","LU1066051498.USD","IE00BVYPNV92.GBP","LU1032466523.USD","IE0009355771.USD","LU1894683348.USD","LU1674673428.USD","LU2129689605.HKD","LU0640476718.USD","BK4592","JNJ","LU0912757837.SGD","IE00B2B36J28.USD","IE00BDGV0183.EUR","IE00BJT1NW94.SGD","LU1066051811.HKD","LU2089984988.USD","LU1894683264.USD","LU2133065610.SGD","IE00B42XCP33.USD","LU1732799900.SGD","LU1162221912.USD","LU0889566641.SGD","LU1066051225.USD","LU0792757196.USD","LU0234570918.USD","IE000M9KFDE8.USD","LU0345769128.USD","LU1506573853.SGD","LU1280957306.USD","LU1244550494.USD"],"gpt_icon":0},{"id":"2518313270","title":"Expectations for J&J Genmab opt-in lowered ahead of news, says Morgan Stanley","url":"https://stock-news.laohu8.com/highlight/detail?id=2518313270","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518313270?lang=en_us&edition=fundamental","pubTime":"2025-03-11 00:36","pubTimestamp":1741624598,"startTime":"0","endTime":"0","summary":"Morgan Stanley says intra-day pressure on Genmab (GMAB) of greater than 5% after Genmab announced that partner Johnson & Johnson (JNJ) has decided ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/expectations-for-jj-genmab-opt-in-lowered-ahead-of-news-says-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/expectations-for-jj-genmab-opt-in-lowered-ahead-of-news-says-morgan-stanley?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["GMAB","LU1506573853.SGD","LU2111349929.HKD","LU1989772840.SGD","LU1244550494.USD","IE0034235303.USD","LU0912757837.SGD","IE00B7SZLL34.SGD","BK4127","LU1674673691.USD","LU0882574055.USD","LU1894683264.USD","LU2129689431.USD","LU1066051225.USD","LU1032955483.USD","LU1066051811.HKD","BK4581","IE00B2B36J28.USD","JNJ","LU1162221912.USD","LU2357305700.SGD","LU0158827948.USD","LU0234572021.USD","BK4550","LU1929549753.HKD","BK4534","LU0345770308.USD","LU1548497426.USD","SG9999002232.USD","IE00BVYPNW00.USD","BK4533","IE00BVYPNV92.GBP","IE0002270589.USD","LU2023251221.USD","BK4585","IE00B1BXHZ80.USD","SG9999001440.SGD","IE00BGHQF631.EUR","LU2468319806.SGD","LU0889566641.SGD","LU1732799900.SGD","IE00B19Z3B42.SGD","LU2089283258.USD","LU2271345857.HKD","LU0640476718.USD","BK4007","LU1059921491.USD","BK4504","LU2112291526.USD","LU2505996681.GBP"],"gpt_icon":0},{"id":"2518271869","title":"Genmab’s HexaBody-CD38 Development Halted After J&J Decision","url":"https://stock-news.laohu8.com/highlight/detail?id=2518271869","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518271869?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:16","pubTimestamp":1741619817,"startTime":"0","endTime":"0","summary":"Genmab ( ($GMAB) ) has shared an announcement. On March 10, 2025, Genmab A/S announced that Johnson & Johnson decided not to exercise its option to...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/genmabs-hexabody-cd38-development-halted-after-jj-decision?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/genmabs-hexabody-cd38-development-halted-after-jj-decision?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","LU1244550494.USD","IE00B4R5TH58.HKD","LU2592432038.USD","LU0889566641.SGD","IE00BJT1NW94.SGD","LU1506573853.SGD","LU2133065610.SGD","LU1059921491.USD","BK4504","LU1894683264.USD","LU1244550577.SGD","BK4568","IE00B7SZLL34.SGD","SG9999002232.USD","LU1221951046.USD","LU1914381329.SGD","LU0466842654.USD","IE00BFTCPJ56.SGD","LU0882574055.USD","IE00BSNM7G36.USD","LU1430594728.SGD","LU2468319806.SGD","BK4533","JNJ","IE00B3PB1722.GBP","IE00B1BXHZ80.USD","IE00B42XCP33.USD","IE00B19Z3B42.SGD","IE0009355771.USD","LU0122379950.USD","LU1066051225.USD","LU2089984988.USD","LU1732799900.SGD","LU2430703251.USD","IE00BGHQF631.EUR","LU0345770993.USD","LU0058720904.USD","LU2112291526.USD","BK4534","IE000M9KFDE8.USD","LU0345770308.USD","LU2129689605.HKD","LU1066053197.SGD","LU1718418525.SGD","LU0640476718.USD","LU1066051498.USD","LU1280957306.USD","LU0203345920.USD","BK4581"],"gpt_icon":0},{"id":"2518795012","title":"BRIEF-J&J's oral drug to treat inflammation-causing condition in colon meets main goal in mid-stage study","url":"https://stock-news.laohu8.com/highlight/detail?id=2518795012","media":"Reuters","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518795012?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:12","pubTimestamp":1741619554,"startTime":"0","endTime":"0","summary":"BRIEF-J&J's oral drug to treat inflammation-causing condition in colon meets main goal in mid-stage studyMarch 10  - Johnson & Johnson JNJ.N:ICOTROKINRA MEETS PRIMARY ENDPOINT OF CLINICAL RESPONSE IN ULCERATIVE COLITIS STUDY AND SHOWS POTENTIAL TO TRANSFORM THE TREATMENT PARADIGM FOR PATIENTSJ&J: ICOTROKINRA WAS WELL TOLERATEDSource text: nPn7xsC0haFurther company coverage: JNJ.N ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nFWN3PT10C:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0795875169.SGD","LU1196500208.SGD","LU1221951129.SGD","LU1066051498.USD","LU0882574055.USD","IE00B1BXHZ80.USD","LU1261432733.SGD","SG9999002232.USD","IE00BFTCPJ56.SGD","LU1914381329.SGD","LU0203347892.USD","LU1585245621.USD","IE00BGHQF631.EUR","LU2602419157.SGD","BK4581","IE00BSNM7G36.USD","IE00B3PB1722.GBP","LU0889566641.SGD","IE0002270589.USD","BK4532","JNJ","LU2129689514.USD","LU0345770308.USD","LU1732799900.SGD","LU2129689605.HKD","LU2129689431.USD","IE00BJJMRZ35.SGD","BK4559","IE00B19Z3B42.SGD","LU2505996681.GBP","SG9999001440.SGD","LU2133065610.SGD","LU1032955483.USD","BK4007","LU0345769631.USD","BK4588","LU1066051811.HKD","IE00B19Z3581.USD","LU0058720904.USD","LU1066053197.SGD","IE00B7SZLL34.SGD","BK4585","LU2112291526.USD","IE00BDGV0183.EUR","LU2430703095.HKD","BK4550","LU1074936037.SGD","LU1506573853.SGD","LU1430594728.SGD","LU0792757196.USD"],"gpt_icon":0},{"id":"2518277123","title":"Zacks Investment Ideas feature highlights: Coca-Cola, Philip Morris and Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2518277123","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518277123?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:06","pubTimestamp":1741619160,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 10, 2025– Today, Zacks Investment Ideas feature highlights Coca-Cola KO, Philip Morris PM and Johnson & Johnson JNJ.The market has thrown a tantrum over recent weeks following tariff news and other economic data pointing to a slowing consumer. While it's certainly been a forgettable period, several stocks, including Coca-Cola, Philip Morris and Johnson & Johnson, have remained strong over the past month.All three reflect defensive deployments, with their products able to carry steady demand through many economic backdrops. Let's take a closer look at each for those interested in adding in an additional layer of defense.Concerning headline figures in KO's latest release, the company exceeded both consensus EPS and sales expectations handily, reflecting growth rates of 12% and 6%, respectively. Notably, the company's gross margin has remained constructive over recent periods, recovering nicely from early 2023 lows.Like those above, the stock is a prime selection for t","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-150600780.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0640476718.USD","LU0289739699.SGD","LU2129689605.HKD","LU1066053197.SGD","LU0957791311.USD","LU1267930813.SGD","IE00B4R5TH58.HKD","IE00B2B36J28.USD","IE00BVYPNW00.USD","LU1023059063.AUD","LU1244550577.SGD","LU0795875086.SGD","LU0265550359.USD","BK4504","LU1066051225.USD","LU0323591593.USD","LU1244550221.USD","LU1066051811.HKD","LU0690374615.EUR","LU1914381329.SGD","LU2506951875.HKD","IE00B19Z3B42.SGD","PM","LU1778281490.HKD","LU2404859667.USD","KO","LU0234572021.USD","LU0661504455.SGD","LU0994945656.USD","SG9999014542.SGD","IE0034235303.USD","LU0114720955.EUR","LU1064131342.USD","LU2279689827.SGD","BK4177","LU1066051498.USD","SFB","LU0823417653.USD","LU2237957811.SGD","IE00BJT1NW94.SGD","LU0823417737.USD","IE00BLSP4239.USD","IE0002141913.USD","LU1674673428.USD","IE00B1BXHZ80.USD","JNJ","LU0426412945.USD","LU1732799900.SGD","LU1280957306.USD","BK4075"],"gpt_icon":1},{"id":"2518527796","title":"Zacks Investment Ideas feature highlights: Gilead Sciences and Johnson & Johnson","url":"https://stock-news.laohu8.com/highlight/detail?id=2518527796","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518527796?lang=en_us&edition=fundamental","pubTime":"2025-03-10 23:02","pubTimestamp":1741618920,"startTime":"0","endTime":"0","summary":"Chicago, IL – March 10, 2025– Today, Zacks Investment Ideas feature highlights Gilead Sciences GILD and Johnson & Johnson JNJ.Medical pioneer Gilead Sciences has seen its stock etch out new 52-week highs as the broader market pulled back sharply in recent weeks. Gilead has joined Johnson & Johnson, and a cluster of healthcare stocks that have risen to fresh peaks.This makes it a worthy topic of whether Gilead's stock can reach higher highs with investors scoping out exposure to the medical sector amid economic uncertainty. Trading at $117 a share, GILD has spiked nearly +30% year to date with the broader market indexes in negative territory.Bringing in $28.75 billion in 2024, Gilead's top line is expected to dip 1% this year but is projected to rebound and rise 4% in fiscal 2026 to $29.7 billion.More intriguing, Gilead's operational efficiency has led the company and its stock back to prominence. Gilead's annual earnings are expected to soar 70% in FY25 to $7.87 per share compared to E","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/zacks-investment-ideas-feature-highlights-150200009.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4578","BK4550","BK4581","LU0203345920.USD","LU0889565916.HKD","LU0114720955.EUR","GILD","IE00B1BXHZ80.USD","JNJ","LU0912757837.SGD","BK4568","LU1066051225.USD","LU0345770993.USD","IE00BDGV0183.EUR","LU1074936037.SGD","BK4559","LU1839511570.USD","LU1032466523.USD","IE00B19Z3581.USD","IE000M9KFDE8.USD","LU0889566641.SGD","LU0234570918.USD","SG9999001440.SGD","LU2087621335.USD","BK4585","LU0795875169.SGD","BK4566","LU1066051811.HKD","LU1244550577.SGD","LU1506573853.SGD","LU1894683348.USD","LU2112291526.USD","LU0882574055.USD","LU1571399168.USD","BK4533","LU1732799900.SGD","LU2602419157.SGD","LU0345769631.USD","IE0002270589.USD","LU0203347892.USD","BK4588","LU0466842654.USD","LU1585245621.USD","LU0345769128.USD","IE00BKVL7J92.USD","LU0122379950.USD","LU1023059063.AUD","LU2468319806.SGD","LU1778281490.HKD","LU2089984988.USD"],"gpt_icon":0},{"id":"2518769512","title":"Genmab Says Johnson & Johnson Declines Global License Option for HexaBody-CD38; Shares Fall","url":"https://stock-news.laohu8.com/highlight/detail?id=2518769512","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518769512?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:58","pubTimestamp":1741618733,"startTime":"0","endTime":"0","summary":"Genmab  said Monday that Johnson & Johnson  has chosen not to exercise its option for a global license to develop, produce, and market HexaBody-CD38.Although the initial HexaBody-CD38 clinical data demonstrated strong efficacy, Genmab has decided not to proceed with further development after evaluating the data, market landscape, and portfolio priorities, the biotechnology company said.Under the development and option agreement between the companies for HexaBody-CD38, Genmab supplied Johnson & Johnson with data from a clinical proof-of-concept study in multiple myeloma, which included a head-to-head comparison with Darzalex Faspro, the company said.Shares of Genmab were down more than 7% in recent Monday trading.Price: 22.23, Change: -1.92, Percent Change: -7.93","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["JNJ","IE0034235303.USD","LU1929549753.HKD","LU1894683264.USD","IE00B3PB1722.GBP","LU0795875086.SGD","SG9999001440.SGD","LU1057294990.SGD","LU0234572021.USD","LU1162221912.USD","IE00B1BXHZ80.USD","LU1732800096.USD","LU0912757837.SGD","BK4534","LU1732799900.SGD","LU1244550221.USD","IE00B19Z3581.USD","IE00BJT1NW94.SGD","LU1196500208.SGD","LU1066051225.USD","LU2430703178.SGD","LU2129689431.USD","IE0009355771.USD","LU1267930813.SGD","IE00BVYPNV92.GBP","LU1718418525.SGD","SG9999002224.SGD","LU1032466523.USD","BK4504","GMAB","LU1032955483.USD","LU2592432038.USD","LU0882574055.USD","BK4588","LU1430594728.SGD","LU1914381329.SGD","IE00BFTCPJ56.SGD","LU1023059063.AUD","LU1778281490.HKD","BK4592","LU0114720955.EUR","LU0792757196.USD","LU1585245621.USD","LU1066051498.USD","BK4532","LU1935042991.SGD","LU2430703251.USD","LU2129689514.USD","BK4550","LU0640476718.USD"],"gpt_icon":0},{"id":"2518927565","title":"Genmab Stops Blood Cancer Treatment Development After J&J Won't License It","url":"https://stock-news.laohu8.com/highlight/detail?id=2518927565","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518927565?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:43","pubTimestamp":1741617780,"startTime":"0","endTime":"0","summary":"Genmab has stopped clinical development of a blood cancer treatment after Johnson & Johnson decided it won't exercise its option to license it.The Copenhagen, Denmark, biotechnology company said Monday Johnson & Johnson has decided it won't exercise its option to receive a worldwide license to develop, manufacture and commercialize HexaBody-CD38, which is designed to treat people with certain blood cancers.Genmab will not pursue further clinical development of the drug, it said, after evaluating the data, market landscape and its own portfolio prioritization.Genmab had provided Johnson and Johsnon with data from a clinical proof-of-concept study for HexaBody-CD38 to treat multiple myeloma. Preliminary data demonstrated an overall response rate of 55%, while the rate of very good partial response or better was 29% and complete response or better was 7%.","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IE00BFTCPJ56.SGD","LU1430594728.SGD","IE00BGHQF631.EUR","IE00B3PB1722.GBP","LU1162221912.USD","LU1023059063.AUD","SG9999002232.USD","LU2430703095.HKD","IE00B19Z3B42.SGD","JNJ","LU1506573853.SGD","IE00B4R5TH58.HKD","LU0234572021.USD","BK4581","LU0792757196.USD","LU0345769631.USD","BK4559","SG9999001440.SGD","BK4588","LU0203345920.USD","LU0122379950.USD","LU0345770308.USD","BK4534","IE00B7SZLL34.SGD","GMAB","LU1280957306.USD","LU1929549753.HKD","LU0345770993.USD","LU1674673691.USD","SG9999002224.SGD","IE00BDGV0183.EUR","LU0289739699.SGD","IE00B2B36J28.USD","IE000M9KFDE8.USD","IE0034235303.USD","IE00B19Z3581.USD","LU2089984988.USD","LU1894683348.USD","BK4550","LU0795875169.SGD","LU1066051225.USD","LU1221951046.USD","BK4592","IE0009355771.USD","LU1066051811.HKD","LU1674673428.USD","LU1914381329.SGD","LU1196500208.SGD","LU0795875086.SGD","LU1732800096.USD"],"gpt_icon":0},{"id":"2518278397","title":"Genmab says J&J not exercising option on HexaBody-CD38","url":"https://stock-news.laohu8.com/highlight/detail?id=2518278397","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518278397?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:20","pubTimestamp":1741616418,"startTime":"0","endTime":"0","summary":"Genmab (GMAB) announced that Johnson & Johnson (JNJ) has decided that it will not exercise its option to receive a worldwide license to develop, ma...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/genmab-says-jj-not-exercising-option-on-hexabody-cd38?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/genmab-says-jj-not-exercising-option-on-hexabody-cd38?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4550","LU0098860793.USD","LU0912757837.SGD","LU1059921491.USD","IE00BFTCPJ56.SGD","IE000M9KFDE8.USD","LU1244550494.USD","BK4559","LU1732799900.SGD","IE00BGHQF631.EUR","IE00BJJMRZ35.SGD","IE0009355771.USD","IE00B2B36J28.USD","BK4585","LU0795875169.SGD","LU1506573853.SGD","SG9999002232.USD","LU0058720904.USD","JNJ","LU1162221912.USD","IE00B19Z3B42.SGD","LU1244550577.SGD","LU1066051225.USD","BK4588","LU2430703178.SGD","LU0320765646.SGD","IE00BDGV0183.EUR","BK4007","LU1585245621.USD","GMAB","LU1674673691.USD","LU0792757196.USD","IE00B19Z3581.USD","LU1032955483.USD","LU2347655156.SGD","LU2112291526.USD","LU1066051498.USD","LU2592432038.USD","SG9999002224.SGD","LU2505996681.GBP","LU1778281490.HKD","LU2430703251.USD","LU2602419157.SGD","LU0345769631.USD","LU1674673428.USD","SG9999001440.SGD","IE00BVYPNV92.GBP","LU1221951129.SGD","IE00B4R5TH58.HKD","LU1074936037.SGD"],"gpt_icon":0},{"id":"2518220675","title":"Genmab a/S - News Does Not Impact Genmab's 2025 Financial Guidance","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220675","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220675?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:13","pubTimestamp":1741615988,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA8D268K:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["LU0345769128.USD","LU0289739699.SGD","IE00B42XCP33.USD","LU2505996681.GBP","LU1057294990.SGD","LU1074936037.SGD","BK4533","LU1061106388.HKD","LU0889566641.SGD","IE0002141913.USD","IE00B19Z3581.USD","BK4581","BK4568","LU0795875169.SGD","LU0234570918.USD","LU2089984988.USD","SG9999002224.SGD","IE0009355771.USD","JNJ","LU1032466523.USD","IE0034235303.USD","LU0058720904.USD","LU1066051811.HKD","BK4550","LU1221951046.USD","IE00BJT1NW94.SGD","LU1430594728.SGD","BK4534","IE00B4R5TH58.HKD","LU1066053197.SGD","LU0345769631.USD","IE00BVYPNV92.GBP","LU0640476718.USD","LU1935042991.SGD","BK4504","BK4559","BK4532","LU0912757837.SGD","LU1066051498.USD","LU2347655156.SGD","IE00B19Z3B42.SGD","LU1914381329.SGD","LU1894683348.USD","IE00BJJMRZ35.SGD","LU0114720955.EUR","LU0345770993.USD","IE00BGHQF631.EUR","BK4592","LU2505996509.AUD","SG9999001440.SGD"],"gpt_icon":0},{"id":"2518220638","title":"Genmab a/S - Johnson & Johnson Will Not Exercise Option for Hexabody-Cd38 License","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220638","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220638?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:13","pubTimestamp":1741615988,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA8D268K:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4568","IE00BJJMRZ35.SGD","IE00BVYPNV92.GBP","IE0009355771.USD","LU1066051225.USD","LU1032466523.USD","IE00BGHQF631.EUR","LU2505996509.AUD","LU0792757196.USD","LU1066053197.SGD","LU1074936037.SGD","LU1261432733.SGD","IE00BJT1NW94.SGD","SG9999002232.USD","IE00B19Z3581.USD","LU1674673428.USD","BK4007","LU2112291526.USD","LU1506573853.SGD","LU2089984988.USD","LU0795875169.SGD","LU2129689431.USD","LU0640476718.USD","LU1221951046.USD","LU0912757837.SGD","IE00B19Z3B42.SGD","IE00BFTCPJ56.SGD","LU0345770993.USD","LU1585245621.USD","LU1032955483.USD","LU2129689514.USD","LU2468319806.SGD","LU1267930813.SGD","LU1718418525.SGD","LU1196500208.SGD","JNJ","LU1162221912.USD","BK4559","BK4550","IE00B2B36J28.USD","LU0289739699.SGD","LU1732800096.USD","BK4581","IE0034235303.USD","IE00B7SZLL34.SGD","LU0320765646.SGD","LU1280957306.USD","IE00B4R5TH58.HKD","LU1023059063.AUD","LU0345769631.USD"],"gpt_icon":0},{"id":"2518220633","title":"Genmab a/S - Will Not Pursue Further Clinical Development of Hexabody-Cd38","url":"https://stock-news.laohu8.com/highlight/detail?id=2518220633","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2518220633?lang=en_us&edition=fundamental","pubTime":"2025-03-10 22:13","pubTimestamp":1741615988,"startTime":"0","endTime":"0","summary":null,"market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20250310:nTUA8D268K:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["IE00B19Z3B42.SGD","IE00BJJMRZ35.SGD","BK4581","LU1023059063.AUD","LU1674673428.USD","LU1162221912.USD","LU2468319806.SGD","IE00B2B36J28.USD","LU2129689431.USD","IE00B7SZLL34.SGD","LU2129689514.USD","BK4007","LU1261432733.SGD","LU0640476718.USD","LU1032955483.USD","IE00BVYPNV92.GBP","LU1585245621.USD","IE00B4R5TH58.HKD","LU0912757837.SGD","LU1718418525.SGD","LU1066051225.USD","LU1267930813.SGD","IE0009355771.USD","IE00BGHQF631.EUR","LU2112291526.USD","LU2089984988.USD","IE00BJT1NW94.SGD","LU1506573853.SGD","LU1732800096.USD","LU1032466523.USD","LU0792757196.USD","LU0345770993.USD","BK4568","LU0320765646.SGD","LU2505996509.AUD","SG9999002232.USD","IE00B19Z3581.USD","LU1074936037.SGD","LU0795875169.SGD","LU1280957306.USD","LU1196500208.SGD","LU1221951046.USD","LU0345769631.USD","LU1066053197.SGD","BK4550","BK4559","LU0289739699.SGD","IE00BFTCPJ56.SGD","JNJ","IE0034235303.USD"],"gpt_icon":0}],"pageSize":20,"totalPage":20,"pageCount":20,"totalSize":400,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/JNJ\",params:#limit:5,,,undefined,":[{"date":"2025-05-27","symbol":"JNJ","amount":1.3,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-05-27","defaultRemindTime":1748352600000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-06-10","payableDate":"2025-05-27","currency":"USD","dateTimestamp":1748318400000,"payDate":"2025-06-10"},{"market":"US","date":"2025-04-15","symbol":"JNJ","fiscalQuarterEnding":"2025/03","expectedEps":2.57,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1744689600000,"reportTimeType":"pre","actualEps":2.77},{"date":"2025-02-18","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-02-18","defaultRemindTime":1739889000000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-03-04","payableDate":"2025-02-18","currency":"USD","dateTimestamp":1739854800000,"payDate":"2025-03-04"},{"market":"US","date":"2025-01-22","symbol":"JNJ","fiscalQuarterEnding":"2024/12","expectedEps":2,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1737522000000,"reportTimeType":"pre","actualEps":2.04},{"date":"2024-11-26","symbol":"JNJ","amount":1.24,"announcedDate":null,"type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-11-26","defaultRemindTime":1732631400000,"name":"强生","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-10","payableDate":"2024-11-26","currency":"USD","dateTimestamp":1732597200000,"payDate":"2024-12-10"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"JNJ\",market:\"US\",,,undefined,":[{"executeDate":"2015-05-21","recordDate":"2015-05-26","paymentDate":"2015-06-09","value":0.75,"currency":"USD"},{"executeDate":"2015-08-21","recordDate":"2015-08-25","paymentDate":"2015-09-08","value":0.75,"currency":"USD"},{"executeDate":"2015-11-20","recordDate":"2015-11-24","paymentDate":"2015-12-08","value":0.75,"currency":"USD"},{"executeDate":"2016-02-19","recordDate":"2016-02-23","paymentDate":"2016-03-08","value":0.75,"currency":"USD"},{"executeDate":"2016-05-20","recordDate":"2016-05-24","paymentDate":"2016-06-07","value":0.8,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"JNJ\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.1923,"buy":0.2692,"hold":0.5385,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.2692,"analysts":26,"updateTime":1744171200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/JNJ\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"JNJ","date":"2025-04-25","current":17.091836,"percent":0.187344,"low":8.579006,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"high":36.412821,"avg":22.732897,"sd":6.732846,"marketCap":372772933115},"quantilePoints":[{"date":"2020-05-01","current":22.759176,"twenty":18.735775,"median":23.109347,"eighty":27.599044,"marketCap":390684023595},{"date":"2020-05-08","current":22.822102,"twenty":19.127953,"median":23.109347,"eighty":27.599044,"marketCap":391764207354},{"date":"2020-05-15","current":23.089153,"twenty":19.382974,"median":23.109347,"eighty":27.599044,"marketCap":396348401845},{"date":"2020-05-22","current":22.157545,"twenty":19.475347,"median":23.109347,"eighty":27.599044,"marketCap":380356413017},{"date":"2020-05-29","current":22.829776,"twenty":19.5115,"median":23.109347,"eighty":27.599044,"marketCap":391895937081},{"date":"2020-06-05","current":22.607234,"twenty":19.590503,"median":23.109347,"eighty":27.599044,"marketCap":388075775005},{"date":"2020-06-12","current":21.816825,"twenty":19.649079,"median":23.109347,"eighty":27.599044,"marketCap":374507613150},{"date":"2020-06-19","current":22.074667,"twenty":19.775373,"median":23.109347,"eighty":27.599044,"marketCap":378933731969},{"date":"2020-06-26","current":21.150732,"twenty":19.950076,"median":23.109347,"eighty":27.599044,"marketCap":363073472868},{"date":"2020-07-02","current":21.635721,"twenty":19.98339,"median":23.109347,"eighty":27.599044,"marketCap":371398791598},{"date":"2020-07-10","current":21.85059,"twenty":20.011787,"median":23.109347,"eighty":27.599044,"marketCap":375087223947},{"date":"2020-07-17","current":25.912196,"twenty":20.076078,"median":23.131106,"eighty":27.599044,"marketCap":393476693802},{"date":"2020-07-24","current":25.681516,"twenty":20.125159,"median":23.159117,"eighty":27.599044,"marketCap":389973813117},{"date":"2020-07-31","current":25.272331,"twenty":20.149539,"median":23.193752,"eighty":27.599044,"marketCap":383760349716},{"date":"2020-08-07","current":25.764739,"twenty":20.181909,"median":23.222825,"eighty":27.599044,"marketCap":391237568385},{"date":"2020-08-14","current":25.702321,"twenty":20.22081,"median":23.257402,"eighty":27.599044,"marketCap":390289751934},{"date":"2020-08-21","current":26.486013,"twenty":20.241265,"median":23.27709,"eighty":27.599044,"marketCap":402190114041},{"date":"2020-08-28","current":26.638591,"twenty":20.271241,"median":23.306845,"eighty":27.599044,"marketCap":404506998699},{"date":"2020-09-04","current":25.763006,"twenty":20.293663,"median":23.353075,"eighty":27.599044,"marketCap":391211240150},{"date":"2020-09-11","current":25.622565,"twenty":20.348379,"median":23.394637,"eighty":27.599044,"marketCap":389078653135},{"date":"2020-09-18","current":25.865302,"twenty":20.493086,"median":23.413631,"eighty":27.599044,"marketCap":392764606000},{"date":"2020-09-25","current":25.254993,"twenty":20.589134,"median":23.432295,"eighty":27.599044,"marketCap":383497067368},{"date":"2020-10-02","current":25.355555,"twenty":20.66024,"median":23.457245,"eighty":27.599044,"marketCap":385024104984},{"date":"2020-10-09","current":26.175658,"twenty":20.718013,"median":23.519753,"eighty":27.599044,"marketCap":397477360020},{"date":"2020-10-16","current":22.955443,"twenty":20.777568,"median":23.52089,"eighty":27.599044,"marketCap":389921156647},{"date":"2020-10-23","current":22.509743,"twenty":20.802059,"median":23.52089,"eighty":27.599044,"marketCap":382350497681},{"date":"2020-10-30","current":21.249731,"twenty":20.852405,"median":23.52089,"eighty":27.599044,"marketCap":360947925757},{"date":"2020-11-06","current":22.046344,"twenty":20.90683,"median":23.52089,"eighty":27.599044,"marketCap":374479195092},{"date":"2020-11-13","current":23.231964,"twenty":20.932588,"median":23.52089,"eighty":27.599044,"marketCap":394618146532},{"date":"2020-11-20","current":22.683324,"twenty":20.94836,"median":23.52089,"eighty":27.599044,"marketCap":385298945473},{"date":"2020-11-27","current":22.317564,"twenty":20.961808,"median":23.52089,"eighty":27.599044,"marketCap":379086144768},{"date":"2020-12-04","current":23.289308,"twenty":20.97761,"median":23.52089,"eighty":27.599044,"marketCap":395592187321},{"date":"2020-12-11","current":23.704663,"twenty":21.021529,"median":23.531213,"eighty":27.599044,"marketCap":402647401682},{"date":"2020-12-18","current":23.946436,"twenty":21.042546,"median":23.534826,"eighty":27.599044,"marketCap":406754168250},{"date":"2020-12-24","current":23.630271,"twenty":21.070826,"median":23.548153,"eighty":27.599044,"marketCap":401383781199},{"date":"2020-12-31","current":24.391238,"twenty":21.097347,"median":23.558663,"eighty":27.599044,"marketCap":414309565719},{"date":"2021-01-08","current":24.803493,"twenty":21.111621,"median":23.586469,"eighty":27.599044,"marketCap":421312129226},{"date":"2021-01-15","current":24.843788,"twenty":21.147258,"median":23.595957,"eighty":27.599044,"marketCap":421996590321},{"date":"2021-01-22","current":25.347483,"twenty":21.183404,"median":23.599747,"eighty":27.599044,"marketCap":430552354005},{"date":"2021-01-29","current":29.186264,"twenty":21.19897,"median":23.614272,"eighty":30.081908,"marketCap":429446686083},{"date":"2021-02-05","current":29.422431,"twenty":21.226117,"median":23.637028,"eighty":30.081908,"marketCap":432921642410},{"date":"2021-02-12","current":29.803518,"twenty":21.248794,"median":23.655744,"eighty":30.081908,"marketCap":438528958301},{"date":"2021-02-19","current":29.159427,"twenty":21.257145,"median":23.669632,"eighty":30.081908,"marketCap":429051804682},{"date":"2021-02-26","current":28.309134,"twenty":21.271585,"median":23.6918,"eighty":30.081908,"marketCap":416540604911},{"date":"2021-03-05","current":27.887517,"twenty":21.285637,"median":23.70506,"eighty":30.12771,"marketCap":410336920526},{"date":"2021-03-12","current":28.556475,"twenty":21.311821,"median":23.72791,"eighty":30.12771,"marketCap":420179968572},{"date":"2021-03-19","current":28.635202,"twenty":21.329473,"median":23.741859,"eighty":30.12771,"marketCap":421338359462},{"date":"2021-03-26","current":29.510146,"twenty":21.34329,"median":23.767845,"eighty":30.081908,"marketCap":434212294590},{"date":"2021-04-01","current":29.134403,"twenty":21.35594,"median":23.773685,"eighty":30.081908,"marketCap":428683610793},{"date":"2021-04-09","current":28.851701,"twenty":21.4211,"median":23.786177,"eighty":30.12771,"marketCap":424523934412},{"date":"2021-04-16","current":29.028837,"twenty":21.428126,"median":23.790128,"eighty":30.12771,"marketCap":427130313916},{"date":"2021-04-23","current":28.830009,"twenty":21.447349,"median":23.796452,"eighty":30.12771,"marketCap":435765591466},{"date":"2021-04-30","current":28.351474,"twenty":21.475831,"median":23.817885,"eighty":30.12771,"marketCap":428532531568},{"date":"2021-05-07","current":29.356747,"twenty":21.503927,"median":23.841105,"eighty":30.12771,"marketCap":443727226505},{"date":"2021-05-14","current":29.656412,"twenty":21.531317,"median":23.877391,"eighty":30.12771,"marketCap":448256667630},{"date":"2021-05-21","current":29.785338,"twenty":21.561813,"median":23.895323,"eighty":30.12771,"marketCap":450205380672},{"date":"2021-05-28","current":29.487415,"twenty":21.592765,"median":23.937312,"eighty":30.12771,"marketCap":445702273507},{"date":"2021-06-04","current":28.91596,"twenty":21.615414,"median":23.966133,"eighty":30.12771,"marketCap":437064734617},{"date":"2021-06-11","current":28.739994,"twenty":21.638518,"median":24.015189,"eighty":30.12771,"marketCap":434405004654},{"date":"2021-06-18","current":28.220806,"twenty":21.670392,"median":24.039278,"eighty":30.12771,"marketCap":426557484565},{"date":"2021-06-25","current":28.609326,"twenty":21.861141,"median":24.084813,"eighty":30.12771,"marketCap":432429957652},{"date":"2021-07-02","current":29.440374,"twenty":21.936844,"median":24.121091,"eighty":30.12771,"marketCap":444991256586},{"date":"2021-07-09","current":29.574527,"twenty":21.9912,"median":24.15923,"eighty":30.12771,"marketCap":447018971509},{"date":"2021-07-16","current":29.287057,"twenty":22.008978,"median":24.192461,"eighty":30.12771,"marketCap":442673868104},{"date":"2021-07-23","current":25.462436,"twenty":22.072979,"median":24.243827,"eighty":30.12771,"marketCap":452391099355},{"date":"2021-07-30","current":25.514348,"twenty":22.099856,"median":24.305908,"eighty":30.12771,"marketCap":453313416242},{"date":"2021-08-06","current":25.64918,"twenty":22.156186,"median":24.365597,"eighty":30.12771,"marketCap":455708974946},{"date":"2021-08-13","current":26.114424,"twenty":22.208673,"median":24.40122,"eighty":30.12771,"marketCap":463974968715},{"date":"2021-08-20","current":26.587076,"twenty":22.280598,"median":24.437878,"eighty":30.12771,"marketCap":472372586588},{"date":"2021-08-27","current":25.62251,"twenty":22.31426,"median":24.507475,"eighty":30.12771,"marketCap":455235128169},{"date":"2021-09-03","current":25.935142,"twenty":22.403746,"median":24.626763,"eighty":30.12771,"marketCap":460789665383},{"date":"2021-09-10","current":24.739435,"twenty":22.438026,"median":24.721919,"eighty":30.12771,"marketCap":439545534901},{"date":"2021-09-17","current":24.410504,"twenty":22.494978,"median":24.721919,"eighty":30.12771,"marketCap":433701424657},{"date":"2021-09-24","current":24.352719,"twenty":22.531175,"median":24.721919,"eighty":30.12771,"marketCap":432674756641},{"date":"2021-10-01","current":23.776349,"twenty":22.581732,"median":24.721919,"eighty":30.12771,"marketCap":422434401303},{"date":"2021-10-08","current":23.844506,"twenty":22.600481,"median":24.721919,"eighty":30.12771,"marketCap":423645343065},{"date":"2021-10-15","current":23.899328,"twenty":22.647017,"median":24.721919,"eighty":30.12771,"marketCap":424619361439},{"date":"2021-10-22","current":24.104584,"twenty":22.670383,"median":24.721919,"eighty":30.12771,"marketCap":430989968102},{"date":"2021-10-29","current":23.981957,"twenty":22.690905,"median":24.721919,"eighty":30.12771,"marketCap":428797394310},{"date":"2021-11-05","current":24.062938,"twenty":22.73421,"median":24.721919,"eighty":30.12771,"marketCap":430245322643},{"date":"2021-11-12","current":24.295572,"twenty":22.75379,"median":24.721919,"eighty":30.12771,"marketCap":434404825854},{"date":"2021-11-19","current":23.98343,"twenty":22.790525,"median":24.721919,"eighty":30.12771,"marketCap":428823720280},{"date":"2021-11-26","current":23.440125,"twenty":22.801141,"median":24.721919,"eighty":30.12771,"marketCap":419109437464},{"date":"2021-12-03","current":23.466628,"twenty":22.824465,"median":24.721919,"eighty":30.12771,"marketCap":419583304919},{"date":"2021-12-10","current":24.366246,"twenty":22.839493,"median":24.721919,"eighty":30.12771,"marketCap":435668472399},{"date":"2021-12-17","current":24.769675,"twenty":22.851504,"median":24.762774,"eighty":30.12771,"marketCap":442881788094},{"date":"2021-12-23","current":24.77262,"twenty":22.874439,"median":24.76352,"eighty":30.12771,"marketCap":442934440034},{"date":"2021-12-31","current":25.187828,"twenty":22.900154,"median":24.774698,"eighty":30.12771,"marketCap":450358363486},{"date":"2022-01-07","current":25.61187,"twenty":22.921295,"median":24.829881,"eighty":30.081908,"marketCap":457940242757},{"date":"2022-01-14","current":24.712253,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":441855075276},{"date":"2022-01-21","current":24.274959,"twenty":22.965167,"median":24.899153,"eighty":30.081908,"marketCap":434036262279},{"date":"2022-01-28","current":21.661741,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":452253833304},{"date":"2022-02-04","current":21.641566,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":451832617789},{"date":"2022-02-11","current":21.147276,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":441512837670},{"date":"2022-02-18","current":20.57272,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":429517246290},{"date":"2022-02-25","current":20.905188,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":436458514228},{"date":"2022-03-04","current":21.343441,"twenty":22.966485,"median":24.899153,"eighty":30.081908,"marketCap":445608367417},{"date":"2022-03-11","current":21.32707,"twenty":22.962882,"median":24.899153,"eighty":30.081908,"marketCap":445266562557},{"date":"2022-03-18","current":22.021361,"twenty":22.953432,"median":24.899153,"eighty":30.081908,"marketCap":459761966327},{"date":"2022-03-25","current":22.28334,"twenty":22.906658,"median":24.899153,"eighty":30.081908,"marketCap":465231566475},{"date":"2022-04-01","current":22.443298,"twenty":22.88299,"median":24.899153,"eighty":30.081908,"marketCap":468571178104},{"date":"2022-04-08","current":22.938288,"twenty":22.87009,"median":24.899153,"eighty":30.081908,"marketCap":478905566846},{"date":"2022-04-14","current":22.658675,"twenty":22.850073,"median":24.899153,"eighty":30.081908,"marketCap":473067820534},{"date":"2022-04-22","current":24.073645,"twenty":22.862939,"median":24.899153,"eighty":30.081908,"marketCap":477380389882},{"date":"2022-04-29","current":23.946685,"twenty":22.897881,"median":24.899153,"eighty":30.081908,"marketCap":474862769549},{"date":"2022-05-06","current":23.40395,"twenty":22.935305,"median":24.899153,"eighty":30.081908,"marketCap":464100336171},{"date":"2022-05-13","current":23.467645,"twenty":22.958017,"median":24.899153,"eighty":30.081908,"marketCap":465363409037},{"date":"2022-05-20","current":23.484896,"twenty":22.975012,"median":24.899153,"eighty":30.081908,"marketCap":465705491271},{"date":"2022-05-27","current":24.030285,"twenty":22.985845,"median":24.899153,"eighty":30.081908,"marketCap":476520552686},{"date":"2022-06-03","current":23.410585,"twenty":23.004816,"median":24.899153,"eighty":30.081908,"marketCap":464231906261},{"date":"2022-06-10","current":22.897044,"twenty":23.050406,"median":24.899153,"eighty":30.081908,"marketCap":454048381280},{"date":"2022-06-17","current":22.487007,"twenty":23.028812,"median":24.899153,"eighty":30.081908,"marketCap":445917349705},{"date":"2022-06-24","current":24.189523,"twenty":23.015811,"median":24.900273,"eighty":30.12771,"marketCap":479678234851},{"date":"2022-07-01","current":23.821949,"twenty":23.040512,"median":24.900273,"eighty":30.12771,"marketCap":472389251854},{"date":"2022-07-08","current":23.657404,"twenty":23.071416,"median":24.900273,"eighty":30.12771,"marketCap":469126313617},{"date":"2022-07-15","current":23.650769,"twenty":23.097851,"median":24.900273,"eighty":30.12771,"marketCap":468994743526},{"date":"2022-07-22","current":24.660616,"twenty":23.102569,"median":24.900273,"eighty":30.12771,"marketCap":452916878504},{"date":"2022-07-29","current":24.983365,"twenty":23.140839,"median":24.928435,"eighty":30.12771,"marketCap":458844475275},{"date":"2022-08-05","current":24.495207,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":449878971833},{"date":"2022-08-12","current":23.663478,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":434603436643},{"date":"2022-08-19","current":24.237528,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":445146448022},{"date":"2022-08-26","current":23.516029,"twenty":23.165705,"median":24.938619,"eighty":30.12771,"marketCap":431895381351},{"date":"2022-09-02","current":23.297002,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":427872736112},{"date":"2022-09-09","current":23.722171,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":435681400400},{"date":"2022-09-16","current":23.992734,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":440650550402},{"date":"2022-09-23","current":23.866758,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":438336872094},{"date":"2022-09-30","current":23.385758,"twenty":23.149852,"median":24.938619,"eighty":30.12771,"marketCap":429502827647},{"date":"2022-10-07","current":22.933389,"twenty":23.145303,"median":24.938619,"eighty":30.12771,"marketCap":421194619179},{"date":"2022-10-14","current":23.543228,"twenty":23.140839,"median":24.938619,"eighty":30.12771,"marketCap":432394925531},{"date":"2022-10-21","current":23.154405,"twenty":23.113317,"median":24.898033,"eighty":30.12771,"marketCap":443568940085},{"date":"2022-10-28","current":23.865676,"twenty":23.113317,"median":24.843788,"eighty":30.12771,"marketCap":457194748356},{"date":"2022-11-04","current":23.40302,"twenty":23.113317,"median":24.803493,"eighty":30.12771,"marketCap":448331648928},{"date":"2022-11-11","current":23.098677,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":442501350484},{"date":"2022-11-18","current":24.04719,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":460672011553},{"date":"2022-11-25","current":24.189125,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":463391074504},{"date":"2022-12-02","current":24.412947,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":467678827620},{"date":"2022-12-09","current":23.98441,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459469349094},{"date":"2022-12-16","current":23.974857,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":459286335241},{"date":"2022-12-23","current":24.22188,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":464018550570},{"date":"2022-12-30","current":24.108604,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":461848529176},{"date":"2023-01-06","current":24.59992,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":471260670161},{"date":"2023-01-13","current":23.669149,"twenty":23.102569,"median":24.803493,"eighty":30.12771,"marketCap":453429891962},{"date":"2023-01-20","current":23.029074,"twenty":23.100329,"median":24.77262,"eighty":30.12771,"marketCap":441167963845},{"date":"2023-01-27","current":24.515611,"twenty":23.09784,"median":24.762774,"eighty":29.79261,"marketCap":439834577205},{"date":"2023-02-03","current":23.98808,"twenty":23.09784,"median":24.725504,"eighty":29.701392,"marketCap":430370146548},{"date":"2023-02-10","current":23.629592,"twenty":23.09784,"median":24.702141,"eighty":29.654503,"marketCap":423938516875},{"date":"2023-02-17","current":23.281951,"twenty":23.096013,"median":24.660616,"eighty":29.589162,"marketCap":417701480138},{"date":"2023-02-24","current":22.640351,"twenty":23.085296,"median":24.603297,"eighty":29.518959,"marketCap":406190534678},{"date":"2023-03-03","current":22.357292,"twenty":23.028549,"median":24.566079,"eighty":29.469644,"marketCap":401112176388},{"date":"2023-03-10","current":22.00746,"twenty":22.983363,"median":24.533047,"eighty":29.415426,"marketCap":394835846397},{"date":"2023-03-17","current":22.198308,"twenty":22.961748,"median":24.507475,"eighty":29.316327,"marketCap":398259841984},{"date":"2023-03-24","current":22.237641,"twenty":22.954123,"median":24.458598,"eighty":29.237465,"marketCap":398965513052},{"date":"2023-03-31","current":22.579982,"twenty":22.928011,"median":24.42796,"eighty":29.164815,"marketCap":405107464940},{"date":"2023-04-06","current":24.125619,"twenty":22.901879,"median":24.415005,"eighty":29.109707,"marketCap":432837724314},{"date":"2023-04-14","current":24.198457,"twenty":22.90067,"median":24.40122,"eighty":29.036089,"marketCap":434144522588},{"date":"2023-04-21","current":33.60045,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":427532123321},{"date":"2023-04-28","current":33.481314,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":426016237324},{"date":"2023-05-05","current":33.113231,"twenty":22.90067,"median":24.399299,"eighty":29.021363,"marketCap":421332755579},{"date":"2023-05-12","current":35.39488,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":450364456873},{"date":"2023-05-16","current":35.078285,"twenty":22.899462,"median":24.396569,"eighty":29.008716,"marketCap":446336102206},{"date":"2023-05-25","current":34.442897,"twenty":22.896558,"median":24.388256,"eighty":28.974086,"marketCap":438251418186},{"date":"2023-06-02","current":33.976799,"twenty":22.896316,"median":24.385274,"eighty":28.964288,"marketCap":432320784926},{"date":"2023-06-09","current":35.234384,"twenty":22.896073,"median":24.383122,"eighty":28.950456,"marketCap":448322304854},{"date":"2023-06-15","current":35.520199,"twenty":22.89583,"median":24.380969,"eighty":28.928156,"marketCap":451959013929},{"date":"2023-06-23","current":36.412821,"twenty":22.894676,"median":24.377907,"eighty":28.919594,"marketCap":463316736116},{"date":"2023-06-30","current":36.078638,"twenty":22.893522,"median":24.372178,"eighty":28.915612,"marketCap":459064583967},{"date":"2023-07-06","current":33.252114,"twenty":22.892945,"median":24.371306,"eighty":28.914218,"marketCap":423099894750},{"date":"2023-07-14","current":32.435159,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":412704958450},{"date":"2023-07-21","current":34.389724,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":437574843548},{"date":"2023-07-28","current":34.577457,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":451374121486},{"date":"2023-08-04","current":33.973355,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":443488171520},{"date":"2023-08-11","current":34.277968,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":447464594998},{"date":"2023-08-18","current":34.644301,"twenty":22.888195,"median":24.366246,"eighty":28.850983,"marketCap":452246699051},{"date":"2023-08-25","current":32.868384,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":429063890273},{"date":"2023-09-01","current":29.823849,"twenty":22.886611,"median":24.365921,"eighty":28.849875,"marketCap":389320523957},{"date":"2023-09-07","current":29.146873,"twenty":22.885028,"median":24.365597,"eighty":28.849755,"marketCap":380483275547},{"date":"2023-09-15","current":30.203841,"twenty":22.879503,"median":24.364936,"eighty":28.833726,"marketCap":394280941321},{"date":"2023-09-20","current":29.919769,"twenty":22.87674,"median":24.363504,"eighty":28.822576,"marketCap":390572668146},{"date":"2023-09-27","current":29.333179,"twenty":22.87009,"median":24.356583,"eighty":28.783898,"marketCap":382915324837},{"date":"2023-10-06","current":28.986391,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":378388342001},{"date":"2023-10-13","current":28.836976,"twenty":22.866716,"median":24.354651,"eighty":28.718771,"marketCap":376437886630},{"date":"2023-10-20","current":10.593286,"twenty":22.841783,"median":24.323515,"eighty":28.702887,"marketCap":366781928558},{"date":"2023-10-27","current":10.362392,"twenty":22.819032,"median":24.302934,"eighty":28.672744,"marketCap":358787469506},{"date":"2023-11-03","current":10.445631,"twenty":22.769044,"median":24.290222,"eighty":28.617079,"marketCap":361669539868},{"date":"2023-11-10","current":10.249567,"twenty":22.737382,"median":24.269161,"eighty":28.577268,"marketCap":354881014160},{"date":"2023-11-17","current":10.435898,"twenty":22.670731,"median":24.240678,"eighty":28.494304,"marketCap":361332520862},{"date":"2023-11-24","current":10.602761,"twenty":22.660327,"median":24.231704,"eighty":28.462978,"marketCap":367109989550},{"date":"2023-11-30","current":10.575646,"twenty":22.651742,"median":24.221347,"eighty":28.351474,"marketCap":366171150888},{"date":"2023-12-08","current":10.804387,"twenty":22.618791,"median":24.198457,"eighty":28.181371,"marketCap":374091097548},{"date":"2023-12-15","current":10.906591,"twenty":22.590739,"median":24.188733,"eighty":27.750808,"marketCap":377629797119},{"date":"2023-12-22","current":10.765452,"twenty":22.58102,"median":24.177986,"eighty":27.241581,"marketCap":372743021520},{"date":"2023-12-29","current":10.886428,"twenty":22.573561,"median":24.160465,"eighty":27.136313,"marketCap":376931686319},{"date":"2024-01-05","current":11.16801,"twenty":22.53203,"median":24.157661,"eighty":27.08647,"marketCap":386681164730},{"date":"2024-01-12","current":11.204163,"twenty":22.487074,"median":24.126144,"eighty":26.963348,"marketCap":387932949613},{"date":"2024-01-19","current":11.208335,"twenty":22.443298,"median":24.121091,"eighty":26.726065,"marketCap":388077386330},{"date":"2024-01-26","current":11.093616,"twenty":22.419215,"median":24.117255,"eighty":26.720851,"marketCap":384105376607},{"date":"2024-02-02","current":10.844498,"twenty":22.388887,"median":24.117255,"eighty":26.720851,"marketCap":381216642263},{"date":"2024-02-09","current":10.710277,"twenty":22.359324,"median":24.117255,"eighty":26.720851,"marketCap":376498376168},{"date":"2024-02-16","current":10.814367,"twenty":22.324374,"median":24.117255,"eighty":26.720851,"marketCap":380157439670},{"date":"2024-02-23","current":10.994416,"twenty":22.309859,"median":24.117255,"eighty":26.720851,"marketCap":386486701732},{"date":"2024-03-01","current":11.058142,"twenty":22.274272,"median":24.113418,"eighty":26.715636,"marketCap":388726855254},{"date":"2024-03-08","current":10.886151,"twenty":22.230938,"median":24.108604,"eighty":26.715636,"marketCap":382680849512},{"date":"2024-03-15","current":10.914049,"twenty":22.186179,"median":24.098462,"eighty":26.715636,"marketCap":383661560027},{"date":"2024-03-22","current":10.676861,"twenty":22.155506,"median":24.095837,"eighty":26.715636,"marketCap":375323710660},{"date":"2024-03-28","current":10.82836,"twenty":22.121795,"median":24.073645,"eighty":26.715636,"marketCap":380649331209},{"date":"2024-04-05","current":10.45407,"twenty":22.051165,"median":24.060772,"eighty":26.720851,"marketCap":367491915735},{"date":"2024-04-12","current":10.199745,"twenty":22.008009,"median":24.060772,"eighty":26.720851,"marketCap":358551620604},{"date":"2024-04-19","current":8.65562,"twenty":21.962919,"median":24.049911,"eighty":26.720851,"marketCap":351201782289},{"date":"2024-04-26","current":8.719762,"twenty":21.891108,"median":24.032177,"eighty":26.715636,"marketCap":353804347988},{"date":"2024-05-03","current":9.377517,"twenty":21.784557,"median":24.00846,"eighty":26.715636,"marketCap":360809343115},{"date":"2024-05-10","current":9.373138,"twenty":21.660958,"median":23.990791,"eighty":26.715636,"marketCap":360640875572},{"date":"2024-05-17","current":9.650236,"twenty":21.622619,"median":23.98343,"eighty":26.715636,"marketCap":371302464353},{"date":"2024-05-24","current":9.363756,"twenty":21.575231,"median":23.974857,"eighty":26.715636,"marketCap":360279873695},{"date":"2024-05-31","current":9.087284,"twenty":21.542202,"median":23.962574,"eighty":26.715636,"marketCap":349642351706},{"date":"2024-06-07","current":9.158591,"twenty":21.483343,"median":23.946685,"eighty":26.715636,"marketCap":352385965974},{"date":"2024-06-14","current":9.097918,"twenty":21.446612,"median":23.929686,"eighty":26.720851,"marketCap":350051487167},{"date":"2024-06-21","current":9.24366,"twenty":21.36611,"median":23.912184,"eighty":26.726065,"marketCap":355659049663},{"date":"2024-06-28","current":9.11981,"twenty":21.343437,"median":23.902291,"eighty":26.770681,"marketCap":350893824881},{"date":"2024-07-05","current":9.11293,"twenty":21.329201,"median":23.877595,"eighty":26.770681,"marketCap":350629090171},{"date":"2024-07-12","current":9.363756,"twenty":21.294957,"median":23.864994,"eighty":26.770681,"marketCap":360279873695},{"date":"2024-07-15","current":9.375015,"twenty":21.282675,"median":23.856229,"eighty":26.770681,"marketCap":360713075948},{"date":"2024-08-02","current":10.179086,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":386988491906},{"date":"2024-08-09","current":10.144894,"twenty":21.325495,"median":23.875766,"eighty":26.859196,"marketCap":385688580326},{"date":"2024-08-16","current":10.073344,"twenty":21.285584,"median":23.875766,"eighty":26.859196,"marketCap":382968394983},{"date":"2024-08-23","current":10.279762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":390816009337},{"date":"2024-08-30","current":10.398801,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":395341627431},{"date":"2024-09-06","current":10.446923,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":397171132618},{"date":"2024-09-13","current":10.424762,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396328597334},{"date":"2024-09-20","current":10.436159,"twenty":21.271585,"median":23.875766,"eighty":26.859196,"marketCap":396761901194},{"date":"2024-09-27","current":10.218977,"twenty":21.249331,"median":23.875766,"eighty":26.859196,"marketCap":388505055417},{"date":"2024-10-04","current":10.162623,"twenty":21.244537,"median":23.875766,"eighty":26.859196,"marketCap":386362608553},{"date":"2024-10-11","current":10.163256,"twenty":21.204151,"median":23.875766,"eighty":26.859196,"marketCap":386386680990},{"date":"2024-10-18","current":26.962637,"twenty":21.150041,"median":23.875766,"eighty":26.960825,"marketCap":395919365911},{"date":"2024-10-25","current":26.835716,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":394055651827},{"date":"2024-10-31","current":26.333991,"twenty":21.150041,"median":23.889093,"eighty":26.967068,"marketCap":386688325532},{"date":"2024-11-08","current":25.697817,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":377346748401},{"date":"2024-11-15","current":24.90096,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":365645700757},{"date":"2024-11-22","current":25.496144,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":374385372146},{"date":"2024-11-29","current":25.415802,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":373205636889},{"date":"2024-12-06","current":24.515649,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":359987786773},{"date":"2024-12-13","current":23.977852,"twenty":21.14935,"median":23.88615,"eighty":26.970043,"marketCap":352090783425},{"date":"2024-12-20","current":23.541712,"twenty":21.14935,"median":23.870477,"eighty":26.963219,"marketCap":345686506319},{"date":"2024-12-27","current":23.869637,"twenty":21.14935,"median":23.866899,"eighty":26.862222,"marketCap":350501752263},{"date":"2025-01-03","current":23.613856,"twenty":21.14935,"median":23.846327,"eighty":26.797423,"marketCap":346745860427},{"date":"2025-01-10","current":23.326922,"twenty":21.148658,"median":23.835219,"eighty":26.622639,"marketCap":342532520226},{"date":"2025-01-17","current":24.228715,"twenty":21.148658,"median":23.815222,"eighty":26.492194,"marketCap":355774446572},{"date":"2025-01-24","current":25.099803,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":353053832614},{"date":"2025-01-31","current":26.166168,"twenty":21.148658,"median":23.815222,"eighty":26.458097,"marketCap":368053323729},{"date":"2025-02-07","current":26.275715,"twenty":21.148658,"median":23.815222,"eighty":26.451023,"marketCap":369594202431},{"date":"2025-02-14","current":26.915876,"twenty":21.148658,"median":23.815222,"eighty":26.482684,"marketCap":378598712347},{"date":"2025-02-21","current":27.331738,"twenty":21.148658,"median":23.815222,"eighty":26.556741,"marketCap":384448233538},{"date":"2025-02-28","current":28.02496,"twenty":21.148658,"median":23.815222,"eighty":26.658356,"marketCap":394199081144},{"date":"2025-03-07","current":28.384408,"twenty":21.147967,"median":23.81824,"eighty":26.827657,"marketCap":399255076200},{"date":"2025-03-14","current":27.898297,"twenty":21.147967,"median":23.837873,"eighty":27.012809,"marketCap":392417444792},{"date":"2025-03-21","current":27.929289,"twenty":21.164087,"median":23.864994,"eighty":27.693395,"marketCap":392853376781},{"date":"2025-03-28","current":27.948135,"twenty":21.248131,"median":23.876669,"eighty":27.88488,"marketCap":393118460031},{"date":"2025-04-04","current":27.381051,"twenty":21.248131,"median":23.905254,"eighty":27.898419,"marketCap":385141864048},{"date":"2025-04-11","current":25.474211,"twenty":21.248531,"median":23.905255,"eighty":27.898389,"marketCap":358320258825},{"date":"2025-04-17","current":17.005945,"twenty":21.223208,"median":23.911283,"eighty":27.898389,"marketCap":370899663970},{"date":"2025-04-25","current":17.091836,"twenty":21.086751,"median":23.911734,"eighty":27.898419,"marketCap":372772933115}],"updateTime":1745783549853}}}